As for the contribution of Bcl-2 in the B-ALL, it has been reported that venetoclax single agent suppressed the growth of a B-ALL cell line or B-ALL patient-derived cells [31], suggesting that Bcl-2 contributes to the cell survival of B-ALL leukemic cells. Here, BCL2 is linked to acute lymphoblastic leukemia.